Efficacy of third-line and later (3L+) therapies post poly (ADP-ribose) polymerase inhibitor (PARPi) exposure in recurrent platinum-sensitive ovarian cancer (PSOC): A pooled clinical trial database ...
Alzheimer’s disease (AD) and related dementias present significant challenges in therapeutic development, particularly within ...
Acute myeloid leukaemia (AML) is mainly characterized by an increase in the number of myeloid cells in the bone marrow and a decrease in mature cells, accounting for 28% of leukaemia cases, with a ...
A groundbreaking review in Biological Diversity proposes a proactive, AI - integrated approach to stop biological invasions ...
Comprehensive Cancer Detection: SeekInCare leverages shallow whole-genome sequencing of cell-free DNA (cfDNA) and measures seven protein tumor markers from 8ml peripheral blood. The test analyzes ...
Recent advances in artificial intelligence (AI) have positioned the field as a transformative technological domain, with applications across many areas. AI ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Vizgen, Inc., a spatial multi-omics innovator accelerating biological discovery and new drug development, today announced that it will present new spatial ...
Traditional analytical approaches often fail to uncover the complexities of biological systems involving many biomolecules. In contrast, omics, an interdisciplinary approach, focuses on understanding ...
Heng et al. apply a multi-omics approach combining analyses of energy metabolism, immune cell composition, and plasma proteomics. They reveal altered energy metabolism and immune profiles, alongside ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback